Fig. 6

Prevalence of humoral response rate after the fourth dose in HSCT recipients. The patients exhibited enhanced antibody response after the second additional dose
Prevalence of humoral response rate after the fourth dose in HSCT recipients. The patients exhibited enhanced antibody response after the second additional dose